+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bifidobacterium Longum Subsp. Infantis M-63 Market - Global Forecast 2026-2032- Product Image
Bifidobacterium Longum Subsp. Infantis M-63 Market - Global Forecast 2026-2032- Product Image
New

Bifidobacterium Longum Subsp. Infantis M-63 Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 184 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082211
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Bifidobacterium longum subsp. infantis M-63 market is experiencing renewed interest from global industry leaders due to its essential role in infant gut health, consumer demand for safe probiotics, and the escalating need for product traceability. Companies are attuned to heightened regulatory expectations and growing scrutiny in early-life nutrition.

Market Snapshot: Growth Outlook and Opportunity Landscape

Between 2025 and 2026, the Bifidobacterium longum subsp. infantis M-63 market expanded from USD 540.19 million to USD 585.64 million, and is projected to achieve a sustained CAGR of 9.25%. The total market value is forecast to reach USD 1.00 billion by 2032. This growth reflects convergence of innovation in infant microbiome science, robust regulatory frameworks, and a marked shift toward clinically proven probiotic ingredients. Demand spans nutritional, supplement, and medical nutrition sectors, with early adopters in infant health and healthcare capitalizing on the evidence-backed safety and efficacy associated with this strain.

Bifidobacterium longum subsp. infantis M-63 Market: Scope & Segmentation

  • Application Segments: Includes infant formula, dietary supplements, growing-up milk, and medical nutrition. Each segment presents distinct formulation requirements and safety protocols, reflecting varying clinical and regulatory demands.
  • Delivery Formats: Spans powder inclusions, oil-based drops, liquid suspensions, emulsions, sachets, capsules, and stick packs. Handling, stability, and caregiver preference considerations vary by format.
  • Distribution Channels: Covers pharmacy and healthcare-focused outlets emphasizing transparency, mass retail noted for supply chain consistency and shelf-life, and e-commerce that highlights packaging resilience and consumer guidance.
  • End-User Groups: Encompasses caregivers, healthcare practitioners, and parents pursuing reliable microbiome solutions for infants and toddlers, with some relevance for select adult digestive health applications.
  • Regional Focus: Encompasses Americas, Europe, Middle East & Africa, and Asia-Pacific, each region influenced by regulatory landscapes, supply chain structures, and patterns of consumer trust.
  • Technology Enablers: Utilizes encapsulation technologies, advanced cryoprotectants, moisture-barrier packaging, and evidence-driven formulation to strengthen quality, stability, and compliance.

Key Takeaways for Senior Decision-Makers

  • Strain identity and genomic verification serve as key market differentiators, helping brands meet evolving expectations of both regulators and premium retailers.
  • Clinical positioning increasingly targets indication-adjacent outcomes, such as digestive tolerance and immune system benefits, demanding coordinated compliance and precision in product communications.
  • Manufacturing optimization involves process resiliency and validation steps to support consistent product quality and maintain performance along supply chains.
  • Infant safety remains a critical focus, requiring certifications, robust contaminant controls, post-market monitoring, and clear labeling to ensure trust and uphold partner relationships.
  • Commercial strategies should adjust to local market needs, optimizing communications, product format, and quality assurance protocols for regional variations.
  • Vendors with strong technical support, co-development capabilities, and comprehensive regulatory documentation provide partners with a lower-risk path to launch.

Tariff Impact on B. longum subsp. infantis M-63 Supply Chains

Imminent changes in U.S. tariffs are set to impact cross-border procurement of key inputs such as fermentation media and custom packaging. Market participants are prioritizing diversification of sourcing, value-added operations review, and enhanced compliance procedures. Standardized documentation and forward-looking scenario planning will underpin resilience, helping to stabilize costs and sustain product availability even in volatile trading conditions.

Methodology & Data Sources

This report combines in-depth secondary research, covering regulatory initiatives, peer-reviewed science, and industry standards, with expert interviews spanning supply, manufacturing, quality, commercialization, and compliance functions. Multiple data perspectives are triangulated to ensure accuracy and deliver reliable, actionable insights for business leaders planning market entry or expansion.

Why This Report Matters

  • Empowers stakeholders with actionable guidance for evidence-based commercialization strategies in the Bifidobacterium longum subsp. infantis M-63 market.
  • Details approaches to reinforce product quality, strengthen supply chain robustness, and achieve compliance in a shifting regulatory landscape.
  • Clarifies evolving market segments, technology priorities, and distribution strategies needed to compete and differentiate in this space.

Conclusion

Long-term success in the Bifidobacterium longum subsp. infantis M-63 market hinges on scientific authentication, market-focused product innovation, and robust supply strategies, all while maintaining full alignment with changing regulatory and consumer demands.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Application
8.1. Animal Feed
8.1.1. Aquaculture Feed
8.1.2. Livestock Feed
8.1.3. Pet Food
8.2. Dietary Supplements
8.2.1. Adult Supplements
8.2.2. Elderly Supplements
8.2.3. Infant Supplements
8.3. Functional Foods
8.3.1. Beverages
8.3.2. Dairy Products
8.3.3. Snack Bars
8.4. Infant Formula
8.4.1. Cow Milk-Based
8.4.2. Hypoallergenic
8.4.3. Soy-Based
8.5. Pharmaceuticals
8.5.1. Adjunctive Therapies
8.5.2. Probiotic Therapeutics
9. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Form
9.1. Capsule
9.1.1. Enteric-Coated
9.1.2. Non-Enteric
9.2. Liquid
9.3. Powder
9.4. Tablet
10. Bifidobacterium Longum Subsp. Infantis M-63 Market, by End User
10.1. Adults
10.2. Children
10.3. Elderly
10.4. Infants
11. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Distribution Channel
11.1. Online
11.2. Offline
12. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Bifidobacterium Longum Subsp. Infantis M-63 Market
16. China Bifidobacterium Longum Subsp. Infantis M-63 Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. BioGaia AB
17.6. Chr. Hansen A/S
17.7. Danone S.A.
17.8. DuPont de Nemours, Inc.
17.9. Evolve Biosystems
17.10. Fengchen Group Co., Ltd.
17.11. Fido Pharma Pvt. Ltd.
17.12. Kerry Group plc
17.13. Lallemand Inc.
17.14. Mead Johnson Nutrition
17.15. Molkem
17.16. Morinaga Milk Industry Co., Ltd.
17.17. Nestlé S.A.
17.18. Probi AB
17.19. Yakult Honsha Co., Ltd.
List of Figures
FIGURE 1. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY AQUACULTURE FEED, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY AQUACULTURE FEED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY AQUACULTURE FEED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIVESTOCK FEED, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIVESTOCK FEED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIVESTOCK FEED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PET FOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PET FOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PET FOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULT SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULT SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULT SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DAIRY PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DAIRY PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SNACK BARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SNACK BARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SNACK BARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COW MILK-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COW MILK-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COW MILK-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HYPOALLERGENIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HYPOALLERGENIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HYPOALLERGENIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SOY-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SOY-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SOY-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PROBIOTIC THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PROBIOTIC THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PROBIOTIC THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ENTERIC-COATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ENTERIC-COATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ENTERIC-COATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY NON-ENTERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY NON-ENTERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY NON-ENTERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CHILDREN, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CHILDREN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CHILDREN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 150. EUROPE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. EUROPE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 153. EUROPE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 154. EUROPE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 155. EUROPE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 156. EUROPE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 157. EUROPE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 158. EUROPE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 159. EUROPE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. EUROPE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 175. AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 176. AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 177. AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 178. AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 179. AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 180. AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 181. AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. ASEAN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. ASEAN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. ASEAN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 198. ASEAN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 199. ASEAN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 200. ASEAN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 201. ASEAN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 202. ASEAN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 203. ASEAN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 204. ASEAN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. ASEAN BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 206. GCC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. GCC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 208. GCC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 209. GCC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 210. GCC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 211. GCC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 212. GCC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 213. GCC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 214. GCC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 215. GCC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. GCC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 228. BRICS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 229. BRICS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 230. BRICS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 231. BRICS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 232. BRICS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 233. BRICS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 234. BRICS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 235. BRICS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 236. BRICS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 237. BRICS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 238. BRICS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 239. G7 BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. G7 BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 241. G7 BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 242. G7 BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 243. G7 BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 244. G7 BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 245. G7 BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 246. G7 BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 247. G7 BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 248. G7 BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 249. G7 BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 250. NATO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 251. NATO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. NATO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 253. NATO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 254. NATO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 255. NATO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 256. NATO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 257. NATO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 258. NATO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 259. NATO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. NATO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 261. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 262. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 263. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 264. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2032 (USD MILLION)
TABLE 265. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2032 (USD MILLION)
TABLE 266. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2032 (USD MILLION)
TABLE 267. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
TABLE 271

Companies Mentioned

The key companies profiled in this Bifidobacterium Longum Subsp. Infantis M-63 market report include:
  • BioGaia AB
  • Chr. Hansen A/S
  • Danone S.A.
  • DuPont de Nemours, Inc.
  • Evolve Biosystems
  • Fengchen Group Co., Ltd.
  • Fido Pharma Pvt. Ltd.
  • Kerry Group plc
  • Lallemand Inc.
  • Mead Johnson Nutrition
  • Molkem
  • Morinaga Milk Industry Co., Ltd.
  • Nestlé S.A.
  • Probi AB
  • Yakult Honsha Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages184
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 585.64 Million
Forecasted Market Value ( USD ) by 2032 $ 1000 Million
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Bifidobacterium Longum Lysate (CAS 96507-89-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Bifidobacterium Longum Lysate (CAS 96507-89-0) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Bifidobacterium - Global Strategic Business Report - Product Image

Bifidobacterium - Global Strategic Business Report

  • Report
  • 293 Pages
  • Global
From
Bifidobacterium Infantis Market - Global Forecast 2026-2032 - Product Image

Bifidobacterium Infantis Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Probiotic Dietary Supplements Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034) - Product Image

Probiotic Dietary Supplements Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • 152 Pages
  • Global
From
Brazil Probiotic Supplements Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034) - Product Image

Brazil Probiotic Supplements Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • 106 Pages
  • Brazil
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.